SME Times is powered by   
Search News
Just in:   • SpiceJet re-introduces 'Zero Change fee' offer  • 'Good' progress made at nuclear talks but issues remain: Iran  • Fiscal package may be on cards to maintain economic recovery amid Covid 2.0  • Striking taxi drivers demands unreasonable: Goa tourism body  • Govt notifies Rs 6k cr PLI scheme for AC, LED light manufacturing 
Last updated: 18 Jul, 2017  

Exports.9.Thmb.jpg 'Pharma exports drop by 8.5 pc to $2.5 bn'

india-pharma-industry.jpg
   Top Stories
» Fiscal package may be on cards to maintain economic recovery amid Covid 2.0
» FICCI writes to 25 CMs on Covid management
» Regulation of insolvent firms' shares still remains a dilemma
» ECLGS 2.0 now covers SMA-1 borrowers
» Forex reserves up by over $4 bn
Saurabh Gupta | 18 Jul, 2017
Due to pricing pressure and stiff competition, the Pharma exports from India during April-May 2017 fell by 8.5 percent to USD 2.5 billion, said a report by Care Ratings.

"The prime reasons for the weak exports were price erosion in the generic market in USA due to consolidation among customers i.e. the distribution channels, increase in competition, absence of blockbuster drugs going off patent and regulatory issues faced by Indian Pharma companies," the report said, released Monday.


This situation continued even during the initial months of the current financial year 2017-18 and exports to USA declined by 23 percent y-o-y to USD 723.4 million during April-May 2017. The total exports from India during the  same period fell by 8.5 percent to USD 2.5 billion," it added.


Of the total exports of USD 16.8 billion during the year 2016
-17, majority of the exports, accounting for 40.6 percent were to the American continent followed by 19.7 percent to Europe, 19.1 percent to Africa and 18.8 percent within Asia.


Among the countries, United States of America is the primar
y export destination for India. Exports to USA have been on a rise since more than a decade. The exports are mainly driven by the cost advantage that India has.


The share of exports to USA in total
drugs & pharma exports from India which was 25.4 percent in 2012 - 13 increased to 33.1 percent in 2016 - 17. For other countries like UK, South Africa, Nigeria, Russia, Brazil, Germany, Australia, the share of each of these countries in total drugs & pharma exports remained in the range of 1.4 percent - 3.3 percent in 2016-17.


In 2012
- 13, exports to USA grew by 14.2 percent y-o-y to USD 3.7 billion and increased in single digit in each of the following two years. In 2015-16, exports to USA surged by 27.8 percent to USD 5.5 billion on a y-o-y basis.


However, the export scenario to USA weakened and it grew by a marginal 1.3 percent to USD 5.6 billion in 2016
- 17, it added.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 18 Apr, 2021
  Daily Poll
COVID-19 has directly affected your business
 Yes
 No
 Can't say
  Commented Stories
» Covid second wave: Lockdown or no lockdown(2)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter